Advisors Asset Management Inc. lifted its position in Visteon Co. (NASDAQ:VC – Free Report) by 52.0% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 5,638 shares of the company’s stock after purchasing an additional 1,929 shares during the quarter. Advisors Asset Management Inc.’s holdings in Visteon were worth $537,000 at the end of the most recent reporting period.
Several other large investors have also recently made changes to their positions in the company. Signaturefd LLC grew its position in Visteon by 70.8% in the second quarter. Signaturefd LLC now owns 287 shares of the company’s stock worth $31,000 after acquiring an additional 119 shares in the last quarter. Mather Group LLC. purchased a new position in Visteon in the second quarter worth about $59,000. KBC Group NV grew its position in Visteon by 37.7% in the third quarter. KBC Group NV now owns 902 shares of the company’s stock worth $86,000 after acquiring an additional 247 shares in the last quarter. Acadian Asset Management LLC purchased a new position in Visteon in the second quarter worth about $89,000. Finally, nVerses Capital LLC grew its position in Visteon by 22.2% in the second quarter. nVerses Capital LLC now owns 1,100 shares of the company’s stock worth $117,000 after acquiring an additional 200 shares in the last quarter. 99.71% of the stock is owned by institutional investors.
Visteon Stock Up 0.7 %
Shares of NASDAQ:VC opened at $92.07 on Thursday. Visteon Co. has a 52-week low of $86.27 and a 52-week high of $131.70. The stock has a market cap of $2.54 billion, a P/E ratio of 5.00, a price-to-earnings-growth ratio of 0.46 and a beta of 1.45. The business’s 50 day moving average is $92.29 and its 200 day moving average is $100.53. The company has a quick ratio of 1.47, a current ratio of 1.82 and a debt-to-equity ratio of 0.24.
Wall Street Analyst Weigh In
Several research analysts recently commented on the company. StockNews.com lowered Visteon from a “buy” rating to a “hold” rating in a research report on Sunday, November 3rd. Barclays cut their target price on Visteon from $145.00 to $140.00 and set an “overweight” rating on the stock in a research note on Tuesday, October 15th. Wells Fargo & Company raised Visteon from an “equal weight” rating to an “overweight” rating and upped their target price for the company from $115.00 to $122.00 in a research note on Friday, September 20th. Morgan Stanley cut their target price on Visteon from $135.00 to $100.00 and set an “equal weight” rating on the stock in a research note on Wednesday, August 14th. Finally, Wolfe Research began coverage on Visteon in a research note on Thursday, September 5th. They set a “peer perform” rating on the stock. Seven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $127.57.
Get Our Latest Research Report on Visteon
Visteon Company Profile
Visteon Corporation, an automotive technology company, designs, manufactures, and sells automotive electronics and connected car solutions for vehicle manufacturers worldwide. The company provides instrument clusters, including analog gauge clusters for 2-D and 3-D display-based devices; information displays that integrate a range of user interface technologies and graphics management capabilities, such as active privacy, TrueColor enhancement, local dimming, cameras, optics, haptic feedback, and light effects; and infotainment and connected car solutions, including scalable Android infotainment for seamless connectivity, as well as onboard artificial intelligence-based voice assistants with natural language understanding.
Featured Articles
- Five stocks we like better than Visteon
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Following Congress Stock Trades
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Visteon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Visteon and related companies with MarketBeat.com's FREE daily email newsletter.